Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions
Go back to Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions| ICAD (NASDAQ: ICAD) | Delayed: 3.87 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.87 | 52 Week High | $6.49 | |||
| Open | $3.87 | 52 Week Low | $2.82 | |||
| Day High | $3.87 | P/E | N/A | |||
| Day Low | $3.87 | EPS | $-0.70 | |||
| Volume | 84 | |||||
| (AMEX: IZOZF) | Delayed: 0.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.18 | 52 Week High | $ | |||
| Open | $0.18 | 52 Week Low | $ | |||
| Day High | $0.18 | P/E | N/A | |||
| Day Low | $0.18 | EPS | $ | |||
| Volume | 10,000 | |||||
